LON:RXB

Rex Bionics (RXB) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
314,960 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RXB stock logo

About Rex Bionics Stock (LON:RXB)

Rex Bionics Plc is engaged in the research and development, manufacture and commercialization of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological trauma, such as stroke or traumatic brain injury, or neurodegenerative disease. The Company develops and commercializes ReX, the hands-free, self-supporting, independently controlled robotic walking device for use in the rehabilitation of people with major mobility impairment. The Company offers two principal products: ReX and ReX P (Personal), which are targeted respectively at the professional neuro-rehabilitation clinic and personal homecare markets. The Company utilizes RAPPER II, which is an open label, single arm, non-randomized, non-comparative registry study of Robot-Assisted Physiotherapy Exercises with the REX Robot powered exercise system preventing unsupported patient ambulation.

RXB Stock News Headlines

Regional Express Holdings Ltd REX
AI finds its first serious application
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
AI finds its first serious application
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Rex Bionics PLC (RXB)
Woman killed in hit and run in Minneapolis
See More Headlines
Receive RXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rex Bionics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • David John Macfarlane
    Chairman of the Board
  • Dominic Crispin Adam Simon
    Chief Executive Officer, Director
  • Jeremy Laurence Curnock-Cook
    Deputy Chairman of the Board
  • K. M. Robinson
    Secretary
  • William L. Hunter M.D.
    Director
  • Joseph Anthony Cucolo
    Non-Executive Director

RXB Stock Analysis - Frequently Asked Questions

How do I buy shares of Rex Bionics?

Shares of RXB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:RXB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners